Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease. [electronic resource]
Producer: 20120517Description: 16 p. digitalISSN:- 1742-4690
- Antigens, Viral -- immunology
- Cells, Cultured
- Human T-lymphotropic virus 1 -- immunology
- Humans
- Immunosuppressive Agents -- administration & dosage
- Interleukin-1beta -- antagonists & inhibitors
- Lipopolysaccharide Receptors -- analysis
- Minocycline -- administration & dosage
- Paraparesis, Tropical Spastic -- drug therapy
- Phagocytes -- chemistry
- T-Lymphocytes, Cytotoxic -- immunology
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.